Anavex Retains Novak Druce Connolly Bove & Quigg to Maximize Value of Intellectual Property Portfolio February 4, 2013
Amyloid toxicity induced by oligomeric Aβ25-35 injection is enhanced after pharmacologic or genetic invalidation of the σ1 chaperone protein January 11, 2013
Implication of the σ1 chaperone protein in adult neurogenesis: Contribution to neuroprotection? January 11, 2013
ANAVEX 2-73 Shown to Block Oxidative Stress, Preventing Onset of Alzheimer’s Disease October 18, 2012
Mitochondrial protection is induced by the novel tetrahydrofuran derivative ANAVEX2-73 after ICV injection of oligomeric Aß25-35 peptide in mice, a nontransgenic Alzheimer’s disease model. October 13, 2012
